Drug Discovery & Development
News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.
BioSkryb Genomics, 1Cell.Ai Partner on Circulating Tumor Cell Analysis
The firms will combine BioSkryb's chemistry with 1Cell.Ai's cell isolation platform, offering services of the codeveloped assay at their respective US labs.
Guardant Health, Pfizer Partner to Use Liquid Biopsy to Aid Cancer Therapy Development
Pfizer intends to use Guardant's blood-based tests in global clinical trials, with specific plans to evaluate the clinical utility of its Reveal assay as clinical trial surrogate endpoint.
Tempus Signs $200M Deal With AstraZeneca, Pathos AI to Develop Multimodal Cancer Foundation Model
The collaboration, under which Tempus will collect data licensing and model development fees, will leverage its repository of de-identified multimodal patient data.
ConcertAI, Bayer Partner to Leverage Patient Data for Precision Oncology Insights
The firms will explore molecular mechanisms and patient responses in cancer to inform development of new therapies.
Reveal Genomics, Ona Therapeutics Partner on Molecular Tumor Analysis
The partnership is aided by a grant of undisclosed size from the Spanish Ministry of Science, Innovation, and Universities.